June 28, 2019

June 28, 2019

Experts at congressional briefing on HPV: It’s ‘time to end cervical cancer’

Healio – June 27

“Every 2 minutes, a woman dies of cervical cancer,” keynote speaker Anna R. Guiliano, PhD, founding director of the Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center, said during the briefing.

 

Moffitt fighting robocalls that target patients, doctors

WUSF – June 27

Scammers spoofing real phone numbers is so problematic that several medical providers – including Moffitt – recently spoke about the issue to Congress.

 

Robocalls are ‘potentially dangerous’ threat to hospitals, including MUSC

WCSC – June 27

In April 2019, Dave Summitt, the chief information security officer for H. Lee Moffitt Cancer Center & Research Institute in Florida, testified before the US House Subcommittee on Communications and Technology of the Committee on Energy and Commerce.

 

Pasco High grad wins top Girl Scout honors for math tutoring program

Tampa Bay Times – June 28

As part of her 600-plus hours in community service, Simonelli has volunteered at Tampa’s Moffitt Cancer Center.

 

AACI Endorses Call for Elimination of HPV-Related Cancers

Newswise – June 27

Today, the Association of American Cancer Institutes (AACI) joined the American Association for Cancer Research (AACR), Biden Cancer Initiative, and Moffitt Cancer Center to host a congressional briefing titled “Let’s End HPV-related Cancers” in Washington, DC. 

 

The time is now to take a shot at eliminating six cancers caused by HPV

STAT – June 27

Anna R Giuliano, Ph.D., is the founding director of the Center for Immunization and Infection Research in Cancer at the Moffitt Cancer Center and a member of the American Association for Cancer Research. 

 

Charlie Crist’s Proposal Cracking Down on Spam Calls Builds Momentum

Florida Daily – June 27

Back in April, Crist reeled in some support for the bill as Federal Communications Commission (FCC) Commissioner Jessica Rosenworcel and almost 20 health care and technology organizations, including BayCare Health System and the Moffitt Cancer Center, threw their support behind his proposal.

 

Ending HPV-Related cancers

Bay News 9

Moffitt Cancer Center  hosted an HPV congressional briefing this afternoon. It’s goal, to update the public on vaccination advances, screening and treatment.

 

Moffitt Cancer Center Partners with TuHURA Biopharma to Develop New Generation of Targeted Immunotherapies

Trial Site News – June 27

Moffitt Cancer Center has inked a licensing deal with TuHURA Biopharma, Inc. a Seattle-based start-up, to develop new immunotherapy treatments for cancer that will apply to a great number of cancers and a larger patient population.

 

 

The 15 hospitals, health systems among the 'Best Places to Work in IT'

Advisory Board – June 27

The hospitals and health systems included on the large organization list are: … H. Lee Moffitt Cancer Center and Research Institute (No. 31)

 

Vycellix Founders Awarded Innovation Grant by Sweden’s Vinnova to Establish New World-Class Research Environment on Development of Next-Generation Natural Killer Cell-based Cancer Immunotherapy

Business Wire – June 27

Headquartered on the Fowler Campus of the Moffitt Cancer Center, Tampa, Florida, Vycellix is a closely-held immunotherapy-focused, discovery company with the mission to fundamentally impact the challenges that currently prevail in the area of cell & gene based-therapies.

 

Tampa Bay employers land among Forbes’ best

Tampa Bay Business Journal – June 26

The fourth- and fifth-best employers in Tampa Bay are the University of South Florida (32nd-best in the state) and Tampa-based Moffitt Cancer Center (49th-best statewide).

 

Immunotherapy Combo Fails Melanoma Test

Medpage Today – June 26

The lessons learned begin with the expectation that the dose and schedule of the drugs are optimal, wrote Vernon K. Sondak, MD, and Nikhil I. Khushalani, MD, of Moffitt Cancer Center in Tampa, Florida. 

 

Dr. Shah on Results of ZUMA-3 Study for ALL

OncLive – June 26

Bijal Shah, MD, associate professor, Department of Malignant Hematology, Moffitt Cancer Center, discusses the results of the phase I/II ZUMA-3 study, which looked at using KTE-X19, an anti-CD19 CAR T-cell therapy, to treat patients with relapsed/refractory acute lymphoblastic leukemia (ALL).

 

Vycellix Announces Formation of Scientific Advisory Board

Business Wire – June 26

The appointments to Vycellix’s SAB include: James Mulé, Ph.D.: Associate Center Director for Translational Science, McGillicuddy Endowed Chair in Melanoma Research/Treatment, and Scientific Director of Cell-based Therapies at Moffitt Cancer Center.

 

Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Higher Risk Myelodysplastic Syndrome (MDS)

PR Newswire – June 26

PRGN-3006 UltraCAR-T is a multigenic CAR-T cell treatment utilizing Precigen's advanced non-viral gene delivery system to co-express a chimeric antigen receptor, membrane-bound interleukin‐15 (mbIL15), and a kill switch for better precision and control in targeting relapsed or refractory AML and higher risk MDS. The study is conducted in collaboration with the Moffitt Cancer Center.

 

Proton therapy coming to Mayo Clinic, new patient tower to Orange Park Medical Center

Florida Times Union – June 26

Mayo in Jacksonville is one of only two so designated centers in Florida, the other being the Moffitt Cancer Center in Tampa.

 

NCCN Names 2019 Young Investigator Award Recipients

The ASCO Post – June 25

… Kedar Kirtane MD, Moffitt Cancer Center, Feasibility of a Digitized Peer-to-Peer Patient Support System for Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation

 

Cancer-stricken boy will see his parents more often. But chemo court fight continues.

Tampa Bay Times – June 25

Dr. Bijal D. Shah, head of the Moffitt Cancer Center’s acute lymphoblastic leukemia program, has told the Tampa Bay Times that natural remedies do nothing for leukemia, while accepted medical treatments are becoming more effective. 

 

Finding 'hope on the run' amid relentless storm clouds

Tallahassee Democrat – June 25

“Mr. Smith’s appointment is at 8:15 a.m. in Tampa at the Moffitt Cancer Center,” I replied.  

 

Girl, 2, rings bell after beating rare form of ovarian cancer after doctors initially dismissed her bloated belly as 'gas'

Daily Mail – June 25

'This is very, very rare,' Dr Robert Wenham, chair of the department of gynecologic Oncology at Moffitt Cancer Center in Tampa, Florida, told DailyMail.com in February.

 

Florida US Navy Veterans Mesothelioma Advocate Urges A Navy Veteran with Mesothelioma in Florida to Aim High for Compensation

EIN Presswire – June 26

For the best possible treatment options in Florida the Florida US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facility with the offer to help a diagnosed Veteran, or their family get to the right physicians at the following hospital: The H. Lee Moffitt Cancer Center in Tampa, Florida.

 

Prestigious Cancer Centers Johns Hopkins and Moffitt Complete Patient Enrollment in Post Approval Study for MarginProbe®, Transforming the Standard of Care for Breast Cancer Patients

Business Wire – June 25

Dune Medical Devices has reached another milestone in their MarginProbe® Post Approval Study (PAS) as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial. 

 

Value cycle market leader also demonstrates the financial and operational benefits of its cloud-based Trisus platform

PR Newswire – June 24

Craneware (CRW.L), the healthcare market leader in automated value cycle solutions, today announced it will be joining Moffitt Cancer Center at the HFMA Annual Conference 2019 to discuss how the organizations are partnering to gain an understanding of AI, and its application to charge capture and denials management. 

 

Bay Area hospitals ask Congress for help fighting robocall epidemic

WTVT – June 23

Moffitt Cancer Center's Dave Summitt testified before Congress on the issue in April, saying the calls go far beyond annoyance

 

Girl, 2, diagnosed with rare ovarian cancer is now cancer free
Essential Baby – June 25

At the time, Dr Robert Wenham, chair of Moffitt Cancer Center's Gynaecological Oncology Program, told Good Morning America that Kenni's condition was "very, very rare".

 

Robocalls are overwhelming hospitals and patients, threatening a new kind of health crisis

Denver Post – June 23

The continued threat to doctors and patients prompted Dave Summitt, the chief information security officer for the H. Lee Moffitt Cancer Center and Research Institute, to take his concerns directly to Congress in March. 

 

Robocalls are overwhelming hospitals, threatening a new kind of health crisis

Chicago Daily Herald – June 23

The continued threat to doctors and patients prompted Dave Summitt, the chief information security officer for the H. Lee Moffitt Cancer Center and Research Institute, to take his concerns directly to Congress in March. 

 

AJMCtv® Interviews, June 2019

AJMC Managed Markets Network – June 23

Michael Kolodziej, MD, Vice President and Chief Innovation Officer at ADVI Health

: I was fortunate enough to moderate a panel on alternative payment models [APMs]. We had a representative from Moffitt Cancer Center, a representative from the Memorial Healthcare System, and a representative from Florida Cancer [Specialists]. So that’s great, because those are 3 very different practice settings, all of [which] are knee-deep in APMs. 

Mayo Will Build Proton Therapy Cancer Treatment Facility In Jacksonville

WJCT – June 24

Mayo Clinic will be one of two National Cancer Institute designated Comprehensive Cancer Centers in Florida once the building is completed, according to Mayo Clinic spokeswoman Tia Ford. The other one is the Moffitt Cancer Center in Tampa, but it doesn't offer proton therapy at its facility.

Werlin: Pfizer set to purchase cancer drug maker Array BioPharma

Sarasota Herald Tribune – June 25

As part of our cancer fundraising efforts, we have invited leading cancer experts from Sarasota Memorial Hospital, Moffitt Cancer Center, Duke Cancer Center, John Hopkins Cancer Center, University of Florida Cancer Center and Medical College of Wisconsin to discuss their state-of-the-art investigation efforts. They conduct research in such disparate areas as the brain, pancreas, breast and the thorax.

 

Troll Watch: Robocalls

NPR: All Things Considered – June 23

They target healthcare centers. NPR's Michel Martin discusses this with Dave Summitt, chief information security officer at the Moffitt Cancer.

 

Lawsuit: Cancer docs accuse AdventHealth of ‘anticompetitive conduct’

Daytona Beach News Journal – June 23

“Cancer is a specialty where we see increasing specialization and exclusivity,” said Jerome Hoffman, AdventHealth’s lead attorney. “That is in essence the model that is being replicated here.”

He cited MD Anderson and Moffitt cancer centers as examples.

 

14th Annual Martinis for Moffitt expects a record-breaking year!

Tampa Bay  Newswire – June 22

The Bay Area Advisors are proud to release new details on their annual fundraiser, Martinis for Moffitt, which benefits Moffitt Cancer Center. The 14th Annual Martinis for Moffitt will be held the evening of July 20th, 2019 at The Straz Center in Downtown Tampa, Florida, with high expectations of another record-breaking year and another sell-out crowd for this annual event. 

 

 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.